Literature DB >> 12724414

Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks.

Matthew H Porteus1, Toni Cathomen, Matthew D Weitzman, David Baltimore.   

Abstract

Gene targeting is the in situ manipulation of the sequence of an endogenous gene by the introduction of homologous exogenous DNA. Presently, the rate of gene targeting is too low for it to be broadly used in mammalian somatic cell genetics or to cure genetic diseases. Recently, it has been demonstrated that infection with recombinant adeno-associated virus (rAAV) vectors can mediate gene targeting in somatic cells, but the mechanism is unclear. This paper explores the balance between random integration and gene targeting with rAAV. Both random integration and spontaneous gene targeting are dependent on the multiplicity of infection (MOI) of rAAV. It has previously been shown that the introduction of a DNA double-stranded break (DSB) in a target gene can stimulate gene targeting by several-thousand-fold in somatic cells. Creation of a DSB stimulates the frequency of rAAV-mediated gene targeting by over 100-fold, suggesting that the mechanism of rAAV-mediated gene targeting involves, at least in part, the repair of DSBs by homologous recombination. Absolute gene targeting frequencies reach 0.8% with a dual vector system in which one rAAV vector provides a gene targeting substrate and a second vector expresses the nuclease that creates a DSB in the target gene. The frequencies of gene targeting that we achieved with relatively low MOIs suggest that combining rAAV vectors with DSBs is a promising strategy to broaden the application of gene targeting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12724414      PMCID: PMC164769          DOI: 10.1128/MCB.23.10.3558-3565.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Stimulation of homologous recombination through targeted cleavage by chimeric nucleases.

Authors:  M Bibikova; D Carroll; D J Segal; J K Trautman; J Smith; Y G Kim; S Chandrasegaran
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 2.  Reverse genetic studies of homologous DNA recombination using the chicken B-lymphocyte line, DT40.

Authors:  E Sonoda; C Morrison; Y M Yamashita; M Takata; S Takeda
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

3.  Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

Authors:  R Zufferey; J E Donello; D Trono; T J Hope
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses.

Authors:  K R Clark; X Liu; J P McGrath; P R Johnson
Journal:  Hum Gene Ther       Date:  1999-04-10       Impact factor: 5.695

5.  Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

Authors:  M A Kay; C S Manno; M V Ragni; P J Larson; L B Couto; A McClelland; B Glader; A J Chew; S J Tai; R W Herzog; V Arruda; F Johnson; C Scallan; E Skarsgard; A W Flake; K A High
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

6.  Introduction of single base substitutions at homologous chromosomal sequences by adeno-associated virus vectors.

Authors:  N Inoue; R Dong; R K Hirata; D W Russell
Journal:  Mol Ther       Date:  2001-04       Impact factor: 11.454

7.  Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids.

Authors:  M Grifman; M Trepel; P Speece; L B Gilbert; W Arap; R Pasqualini; M D Weitzman
Journal:  Mol Ther       Date:  2001-06       Impact factor: 11.454

8.  Chromosomal effects of adeno-associated virus vector integration.

Authors:  Daniel G Miller; Elizabeth A Rutledge; David W Russell
Journal:  Nat Genet       Date:  2002-01-22       Impact factor: 38.330

9.  Human gene targeting by viral vectors.

Authors:  D W Russell; R K Hirata
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

10.  Analysis of gene targeting and intrachromosomal homologous recombination stimulated by genomic double-strand breaks in mouse embryonic stem cells.

Authors:  G Donoho; M Jasin; P Berg
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

View more
  70 in total

Review 1.  Zinc-finger nucleases for somatic gene therapy: the next frontier.

Authors:  Shamim H Rahman; Morgan L Maeder; J Keith Joung; Toni Cathomen
Journal:  Hum Gene Ther       Date:  2011-07-22       Impact factor: 5.695

2.  Chromosomal site-specific double-strand breaks are efficiently targeted for repair by oligonucleotides in yeast.

Authors:  Francesca Storici; Christopher L Durham; Dmitry A Gordenin; Michael A Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-20       Impact factor: 11.205

3.  Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses.

Authors:  Manu Kohli; Carlo Rago; Christoph Lengauer; Kenneth W Kinzler; Bert Vogelstein
Journal:  Nucleic Acids Res       Date:  2004-01-02       Impact factor: 16.971

4.  Directional motion of foreign plasmid DNA to nuclear HP1 foci.

Authors:  Vladan Ondrej; Stanislav Kozubek; Emílie Lukásová; Martin Falk; Pavel Matula; Petr Matula; Michal Kozubek
Journal:  Chromosome Res       Date:  2006-07-12       Impact factor: 5.239

Review 5.  Targeted gene therapies: tools, applications, optimization.

Authors:  Olivier Humbert; Luther Davis; Nancy Maizels
Journal:  Crit Rev Biochem Mol Biol       Date:  2012 May-Jun       Impact factor: 8.250

Review 6.  Viral manipulation of DNA repair and cell cycle checkpoints.

Authors:  Mira S Chaurushiya; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2009-05-26

7.  Expanding or restricting the target site repertoire of zinc-finger nucleases: the inter-domain linker as a major determinant of target site selectivity.

Authors:  Eva-Maria Händel; Stephen Alwin; Toni Cathomen
Journal:  Mol Ther       Date:  2008-11-11       Impact factor: 11.454

Review 8.  Development of gene therapy for blood disorders: an update.

Authors:  Arthur W Nienhuis
Journal:  Blood       Date:  2013-07-10       Impact factor: 22.113

9.  Zinc-finger nuclease-induced gene repair with oligodeoxynucleotides: wanted and unwanted target locus modifications.

Authors:  Sarah Radecke; Frank Radecke; Toni Cathomen; Klaus Schwarz
Journal:  Mol Ther       Date:  2010-01-12       Impact factor: 11.454

10.  AAV-mediated gene editing via double-strand break repair.

Authors:  Matthew L Hirsch; R Jude Samulski
Journal:  Methods Mol Biol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.